Abstract:Background: Proline has attracted growing interest because of its diverse influence on tumor metabolism and the discovery of the regulatory mechanisms that appear to be involved. In contrast to general oncology, data on proline metabolism in central nervous system malignancies are limited. Materials and Methods: We performed a systematic literature review of the MEDLINE and EMBASE databases according to PRISMA guidelines, searching for articles concerning proline metabolism in malignant glial tumors. From 815 … Show more
“…Next, we assessed the mRNA levels of enzymes of the urea cycle and proline metabolism, since the polyamine precursor putrescine is synthesized from a non-proteinogenic amino acid ornithine of this cycle, which is also linked to Pro/Glu metabolic system [ 12 , 52 ]. The results, presented in Figure 5 a–c, show that in hepatocyte-like HepaRG cells, the level of the transcript encoding argininosuccinate synthase (ASS1) is fifteen-fold higher than in Huh7.5 cells, and the mRNA of the argininosuccinate lyase gene (ASL), which synthesizes arginine, is two times higher.…”
Section: Resultsmentioning
confidence: 99%
“…In Huh7.5 hepatoma cells, the expression of proteins synthesizing proline from P5C (PYCR1, PYCR2, PYCR3) prevails over proline-utilizing proteins (PRODH and PRODH2) and the coordinated action of PYCR3, PRODH, and PRODH2 proteins. P5C, being exported into the cytoplasm, is converted into proline, resulting in proline being transferred back to the mitochondria, where it was again oxidized into P5C by PRODH and PRODH2 [ 52 ]. Hence, a closed cycle leads to an increase in the concentration of NADP + in the cytoplasm and the generation of ROS in mitochondria [ 73 ].…”
Reactive oxygen species (ROS) play a major role in the regulation of various processes in the cell. The increase in their production is a factor contributing to the development of numerous pathologies, including inflammation, fibrosis, and cancer. Accordingly, the study of ROS production and neutralization, as well as redox-dependent processes and the post-translational modifications of proteins, is warranted. Here, we present a transcriptomic analysis of the gene expression of various redox systems and related metabolic processes, such as polyamine and proline metabolism and the urea cycle in Huh7.5 hepatoma cells and the HepaRG liver progenitor cell line, that are widely used in hepatitis research. In addition, changes in response to the activation of polyamine catabolism that contribute to oxidative stress were studied. In particular, differences in the gene expression of various ROS-producing and ROS-neutralizing proteins, the enzymes of polyamine metabolisms and proline and urea cycles, as well as calcium ion transporters between cell lines, are shown. The data obtained are important for understanding the redox biology of viral hepatitis and elucidating the influence of the laboratory models used.
“…Next, we assessed the mRNA levels of enzymes of the urea cycle and proline metabolism, since the polyamine precursor putrescine is synthesized from a non-proteinogenic amino acid ornithine of this cycle, which is also linked to Pro/Glu metabolic system [ 12 , 52 ]. The results, presented in Figure 5 a–c, show that in hepatocyte-like HepaRG cells, the level of the transcript encoding argininosuccinate synthase (ASS1) is fifteen-fold higher than in Huh7.5 cells, and the mRNA of the argininosuccinate lyase gene (ASL), which synthesizes arginine, is two times higher.…”
Section: Resultsmentioning
confidence: 99%
“…In Huh7.5 hepatoma cells, the expression of proteins synthesizing proline from P5C (PYCR1, PYCR2, PYCR3) prevails over proline-utilizing proteins (PRODH and PRODH2) and the coordinated action of PYCR3, PRODH, and PRODH2 proteins. P5C, being exported into the cytoplasm, is converted into proline, resulting in proline being transferred back to the mitochondria, where it was again oxidized into P5C by PRODH and PRODH2 [ 52 ]. Hence, a closed cycle leads to an increase in the concentration of NADP + in the cytoplasm and the generation of ROS in mitochondria [ 73 ].…”
Reactive oxygen species (ROS) play a major role in the regulation of various processes in the cell. The increase in their production is a factor contributing to the development of numerous pathologies, including inflammation, fibrosis, and cancer. Accordingly, the study of ROS production and neutralization, as well as redox-dependent processes and the post-translational modifications of proteins, is warranted. Here, we present a transcriptomic analysis of the gene expression of various redox systems and related metabolic processes, such as polyamine and proline metabolism and the urea cycle in Huh7.5 hepatoma cells and the HepaRG liver progenitor cell line, that are widely used in hepatitis research. In addition, changes in response to the activation of polyamine catabolism that contribute to oxidative stress were studied. In particular, differences in the gene expression of various ROS-producing and ROS-neutralizing proteins, the enzymes of polyamine metabolisms and proline and urea cycles, as well as calcium ion transporters between cell lines, are shown. The data obtained are important for understanding the redox biology of viral hepatitis and elucidating the influence of the laboratory models used.
“…Current literatures found that the concentration of proline in GBM was higher than in normal brain 32 . Similarly, IDH-mutant high-grade oligodendrogliomas was found to utilize the proline cycle as a redox shuttle to maintain redox balance 33 . Our findings support the hypothesis that regulating the disorder of arginine and proline metabolism pathway in cancer cells can affect the proliferation of tumor cells, which provides a new idea for the targeted therapy of glioma.…”
Anlotinib, as a promising oral small-molecule antitumor drug, its role in glioma has been only reported in a small number of case reports. Therefore, anlotinib has been considered as a promising candidate in glioma. The aim of this study was to investigate the metabolic network of C6 cells after exposure to anlotinib and to identify anti-glioma mechanism from the perspective of metabolic reprogramming. Firstly, CCK8 method was used to evaluate the effects of anlotinib on cell proliferation and apoptosis. Secondly, ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS)-based metabolomic and lipidomic were developed to characterize the metabolite and lipid changes in cell and cell culture medium (CCM) caused by anlotinib in the treatment of glioma. As a result, anlotinib had concentration-dependent inhibitory effect with the concentration range. In total, twenty-four and twenty-three disturbed metabolites in cell and CCM responsible for the intervention effect of anlotinib were screened and annotated using UHPLC-HRMS. Altogether, seventeen differential lipids in cell were identified between anlotinib exposure and untreated groups. Metabolic pathways, including amino acid metabolism, energy metabolism, ceramide metabolism, and glycerophospholipid metabolism, were modulated by anlotinib in glioma cell. Overall, anlotinib has an effective treatment against the development and progression of glioma, and these remarkable pathways can generate the key molecular events in cells treated with anlotinib. Future research into the mechanisms underlying the metabolic changes is expected to provide new strategies for treating glioma.
“…Proline is oxidized to glutamate in the mitochondria and has been linked to glutamate metabolism in GBM and cell proliferation (Cappelletti et al, 2018). In a recent systematic review, Sawicka et al found proline to be a prognostic factor and a signal of malignancy (Sawicka et al, 2022).…”
Gliomas are central nervous system (CNS) cancers that are challenging to treat due to their high proliferation and mutation rates. High grade gliomas include grade 3 and grade 4 tumors, which characteristically have a poor prognosis despite advancements in diagnostic methods and therapeutic options. Advances in metabolomics are resulting in more insight as to how cancer modifies the metabolism of the cell and surrounding tissue. Hence, this avenue of research may also emerge as a way to precisely target metabolites unique to gliomas. These biomarkers may provide opportunities for glioma diagnosis, prognosis and future therapeutic intervention.
In this review, we harvest the literature that highlights notable biomolecules in high grade gliomas and promising therapeutic targets and interventions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.